GALECTIN THERAPEUTICS INC — Director's Dealing 2014

May 15, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2014-05-13

Reporting Person: Martin Rod D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-13	Common Stock	M	83334	$1.80	Acquired	174822	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-13	Option (Right to buy)	$1.80	M	83334	Disposed	2015-02-01	Common Stock (83334)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2776186	Indirect

Footnotes

F1: Reporting person is a managing member of 10X Capital Management, LLC, a Florida limited liability company acting as the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such, may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. Mr. Martin disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F2: Half of the options vested upon grant date, and the remainder vested in four equal parts quarterly over one year from the date of the option grant.